Literature DB >> 17716621

Structural analysis of obscurin gene in hypertrophic cardiomyopathy.

Takuro Arimura1, Yuji Matsumoto, Osamu Okazaki, Takeharu Hayashi, Megumi Takahashi, Natsuko Inagaki, Kunihiko Hinohara, Naoto Ashizawa, Keisuke Yano, Akinori Kimura.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by left ventricular hypertrophy with diastolic dysfunction. Molecular genetic studies have revealed that HCM is caused by mutations in genes for sarcomere/Z-band components including titin/connectin and its associate proteins. However, disease-causing mutations can be found in about half of the patients, suggesting that other disease-causing genes remain to be identified. To explore a novel disease gene, we searched for obscurin gene (OBSCN) mutations in HCM patients, because obscurin interacts with titin/connectin. Two linked variants, Arg4344Gln and Ala4484Thr, were identified in a patient and functional analyses demonstrated that Arg4344Gln affected binding of obscurin to Z9-Z10 domains of titin/connectin, whereas Ala4484Thr did not. Myc-tagged obscurin showed that Arg4344Gln impaired obscurin localization to Z-band. These observations suggest that the obscurin abnormality may be involved in the pathogenesis of HCM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716621     DOI: 10.1016/j.bbrc.2007.07.183

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

Review 1.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 2.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 3.  Titin is a major human disease gene.

Authors:  Martin M LeWinter; Henk L Granzier
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

4.  Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.

Authors:  Nicole A Perry; Marey Shriver; Marie G Mameza; Bryan Grabias; Eric Balzer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

Review 5.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

6.  Obscurin Variants in Patients With Left Ventricular Noncompaction.

Authors:  Teisha J Rowland; Sharon L Graw; Mary E Sweet; Marta Gigli; Matthew R G Taylor; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2016-11-15       Impact factor: 24.094

7.  Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.

Authors:  Maegen A Ackermann; Brendan King; Nicole A P Lieberman; Prameela J Bobbili; Michael Rudloff; Christopher E Berndsen; Nathan T Wright; Peter A Hecker; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Mol Cell Cardiol       Date:  2017-08-04       Impact factor: 5.000

Review 8.  Obscure functions: the location-function relationship of obscurins.

Authors:  Heather R Manring; Olivia A Carter; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2017-03-29

9.  New aspects of obscurin in human striated muscles.

Authors:  Lena Carlsson; Ji-Guo Yu; Lars-Eric Thornell
Journal:  Histochem Cell Biol       Date:  2008-03-19       Impact factor: 4.304

10.  Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.

Authors:  Maegen A Ackermann; Li-Yen R Hu; Amber L Bowman; Robert J Bloch; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Mol Biol Cell       Date:  2009-04-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.